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ABSTRACT 
In order to explore the structure – activity relationship of quinazolinone moiety for anti-bacterial activity against Salmonella 
typhimurium, a series of 4(3H) – quinazolinone derivatives were subjected to Comparative molecular field analysis (CoMFA) and 
Comparative Molecular Similarity Indices Analysis (CoMSIA) methods. The best models for CoMFA and CoMSIA had correlation 
coefficient of 0.905 & 0.868 and cross-validated correlation coefficient of 0.501 & 0.592 respectively. The information obtained 
from the above models might be useful in designing of quinazolinone moiety as potent anti-bacterial agents. 
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INTRODUCTION: 
Bacterial infections are becoming untreatable due to 
development of resistance in bacteria against the 
presently available anti – bacterial agents. This condition 
presents an immense need to search a new agent which 
could be effective against the bacteria. Quinazoline and 
quinazolinone derivatives have been widely studied for 
its diverse pharmacological activities. Of these, studies 
reveals 4- (3H)- quinazolinone derivatives as a potential 
moiety for anti – bacterial activity. There are three main 
positions (R1, R2, R3) which can be varied in 
quinazolinone nucleus for variation in biological activity 
(Fig.1). Literatures also reveal that the variationat 
R1position bring changes in anti – bacterial activity gram 
negative bacteria
1
.  
MATERIALS AND METHODS: 
The antibacterial activities of 4 (3H) – quinazolinone 
derivatives (Table 1) against Salmonella typhimurium 
were taken from the work of Mohamed et al.
2
. The 
activities reported as zone of inhibition (ZOI) were 
converted to natural logarithm of zone of inhibition 
(lnZOI) (Table 2).  
 
Figure 1: 4- (3H) quinazolinone moiety 
The predictive power of QSAR was analysed by 
dividing the dataset into training set and test set. 
 
Figure 2: Structure alignment of molecules of 6, 8-
dibromo-4(3H) quinazolinone derivatives (training) 
Structural Alignment: The molecules taken in training 
set were aligned on the common template of 
quinazolinone. 
CoMFA: Steric (S) and Electrostatic (E) fields were 
calculated using sp
3
 hybridised carbon atom with +1 
charge at each lattice of 2 Ansgstrom and the default 
energy cut off of 30 kCal/mol. Gasteiger, Gasteiger-
Huckel, MMFF_94, DelRe and Pullman charges were 
used to generate the partial charges on the molecules 
under study and generated models were explored models 
for the best models. 
CoMSIA: CoMSIA descriptors i.e. Steric (S), 
Electrostatic (E), Hydrophobic (H), Hydrogen bond 
donor (D) and Hydrogen bond acceptor (A), were 
generated using a sp
3 
hybridized carbon atom with +1 
charge; the attenuation factor was set to 0.3 and a 
Vanderwaals radius of 1.4 Angstrom. 
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Partial Least Square and Predictive r
2
 analysis: 
Leave one out (LOO) validation method was used to 
calculate optimum number of components while no 
validation approach was adopted for the predictability of 
the developed model. R
2
pred value is calculated for test 
set molecules and can be mathematically represented as; 
R
2
pred = 1- (PRESS/SD) 
where SD is the sum of squared deviation between the 
biological activities of the test set molecules to the mean 
activity of the training set molecules, while PRESS is 
the sum of squared deviations between the observed the 
predicted activities of the test molecules. 
 
Table 1 : Structures of the molecules considered for QSAR studies 
 
Template 
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NHN
O
 
 
II III Iva IVb IVc 
 
  
 
 
IVd IVe IVf IVg IVh 
  
 
 
 
Va Vb Vc Vd Via 
 
 
  
 
VIb VIc VId VIIa VIIb 
  
 
 
 
VIIc VIII IX X XI 
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Table 2: Experimental and predicted activities of 6,8-dibromo-4 (3H) quinazolinone derivatives with ZOI and lnZOI 
values of bacteria Salmonella typhimurium 
XII XIII XIV 
Comp. ZOI 
(mm) 
lnZOI Comp. ZOI 
(mm) 
lnZOI Comp. ZOI (mm) lnZOI 
Training 
II 16 2.7726 IVg 12 2.4849 VIII 12 2.4849 
III 11 2.3979 IVh 16 2.7726 IX 14 2.6391 
IVb 10 2.3026 Vb 12 2.4849 X 14 2.6391 
IVc 15 2.7081 VIa 11 2.3979 XI 14 2.6391 
IVd 10 2.3026 VIb 10 2.3026 XIII 17 2.8332 
IVe 11 2.3979 VIIb 16 2.7726 XIV 11 2.3979 
IVf 13 2.5649 VIIc 12 2.4849 XV 18 2.8904 
Test 
IVa 10 2.3026 Vd 12 2.4849 VIIa 16 2.7726 
Va 16 2.7726 VIc 15 2.7081 XII 12 2.4849 
Vc 15 2.7081 VId 18 2.8904    
 
RESULTS AND DISCUSSION: 
The best model was screened out on the basis of Q
2 
(Crossvalidated R
2) ≥ 0.5 and R2 > 0.6 (Table 3). The 
model was validated plotting the graph between 
observed biological activity versus predicted CoMFA 
and CoMSIA activity (Table 4). This revealed that the 
model is validated and contain proper training and test 
sets for further study. 
 
Table 3: CoMFA and CoMSIA statistical results and field contribution of training sets of 6,8-dibromo – 4 (3H) 
quinazolinone derivatives with for bacteria Salmonella typhimurium (Charge: MMFF_94) 
Parameters CoMFA CoMSIA Parameters CoMFA CoMSIA 
Q
2
(Crossvalidated R
2
) 0.501 0.592 Steric field 0.407 0.223 
R
2 
0.905 0.868 Electrostatic field 0.593 0.777 
F value 38.218 37.274 (N1, N2 ) for F 4,16 3,17 
SEE 0.064 0.073 R
2
pred 0.494 0.513 
No. of components 4 3    
 
Table 4: CoMFA and CoMSIA predicted activities of 6,8- dibromo-4(3H)quinazolinone series for bacteria Salmonella 
typhimurium 
Comp CoMFA CoMSIA Comp CoMFA CoMSIA 
Predicted Residual Predicted Residual Predicted Residual Predicted Residual 
Training 
II 2.7231 0.0495 2.7224 0.0502 VIb 2.2586 0.044 2.314 -0.0114 
III 2.4083 -0.0104 2.453 -0.0551 VIIb 2.7372 0.0354 2.82 -0.0474 
IVb 2.3496 -0.047 2.3632 -0.0606 VIIc 2.4493 0.0356 2.4765 0.0084 
IVc 2.5231 0.185 2.5345 0.1736 VIII 2.4905 -0.0056 2.4654 0.0195 
IVd 2.4163 -0.1137 2.4628 -0.1602 IX 2.654 -0.0149 2.6223 0.0168 
IVe 2.3976 0.0003 2.4301 -0.0322 X 2.6626 -0.0235 2.7264 -0.0873 
IVf 2.5718 -0.0069 2.5638 0.0011 XI 2.6157 0.0234 2.6258 0.0133 
IVg 2.5106 -0.0257 2.4552 0.0297 XIII 2.8787 -0.0455 2.8399 -0.0067 
IVh 2.7853 -0.0127 2.7229 0.0497 XIV 2.4157 -0.0178 2.3062 0.0917 
Vb 2.4612 0.0237 2.4561 0.0288 XV 2.9076 -0.0172 2.8825 0.0079 
VIa 2.4541 -0.0562 2.4277 -0.0298      
Test 
IVa 2.5532 -0.2506 2.5722 -0.2696 VIc 2.2569 0.4512 2.3145 0.3936 
Va 2.5271 0.2455 2.4747 0.2979 VId 2.3866 0.5038 2.3424 0.548 
Vc 2.5283 0.1798 2.4856 0.2225 VIIa 2.4847 0.2879 2.4453 0.3273 
Vd 2.4456 0.0393 2.3438 0.1411 XII 2.6019 -0.117 2.7322 -0.2473 
Graphs: 
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Contour maps: In steric contour map, yellow colours shows steric group is unfavourable while green colour shows steric group is 
favourable. In electrostatic contour map, red colour shows electronegative group while blue group favours electropostive group. 
 
  
  
Figure 3: a) CoMFA–Steric b) CoMFA–Electrostatic c) CoMSIA– Steric d) CoMSIA –Electrostatic 
 
Figure 4: Structure activity relationship on the basis of QSAR studies 
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Region_1: Non steric group with small positive charge attachments on it may be good for activity. 
Region_2: Steric group with small hydrophobic and positive attachment may improve the activity. 
Region_3: Less bulky group with negative substituents may be beneficial for anti-bacterial activity. 
 
CONCLUSION: 
3D-QSAR models developed in our present study are 
quite reliable based on appropriate statistical parameters 
and proper validation of test set. Though CoMFA 
method afforded slightly better predictability, models 
from both CoMFA and CoMSIA were utilized in 
development of SAR. The designed model could serve 
as a guideline for further study or development of novel 
anti-bacterial agent against Salmonella typhimurium. 
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